The Choice of Gadolinium-Based Contrast Agents: A Radiologist’s Responsibility Between Pharmaceutical Equivalence and Bioethical Issues

Symmetry - Switzerland
doi 10.3390/sym9110287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Safety of Gadolinium-Based Contrast Agents in Patients With Stage 4 and 5 Chronic Kidney Disease: A Radiologist’s Perspective

Kidney360
2020English

Brain Gadolinium Deposition After Administration of Gadolinium-Based Contrast Agents

Japanese Journal of Radiology
Nuclear MedicineRadiologyImaging
2015English

Gadolinium-Based Contrast Agents for Magnetic Resonance Cancerimaging

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
MedicineBioengineeringNanotechnologyBiomedical EngineeringNanoscience
2012English

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance

PLoS ONE
Multidisciplinary
2016English

Macrocyclic Gadolinium-Based Contrast Agents Do Not Cause Hyperintensity in the Dentate Nucleus

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2016English

Silica Microparticles as a Solid Support for Gadolinium Phosphonate Magnetic Resonance Imaging Contrast Agents

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2012English

Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent

English

Retrospective Analysis of Patients for Development of Nephrogenic Systemic Fibrosis Following Conventional Angiography Using Gadolinium-Based Contrast Agents

European Radiology
MedicineNuclear MedicineRadiologyImaging
2009English

Safety of Gadolinium-Based Contrast Material in Sickle Cell Disease

Journal of Magnetic Resonance Imaging
Nuclear MedicineRadiologyImaging
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy